|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1995-11-21
|
|
pubmed:abstractText |
Optimal insulin regimens for non-insulin-dependent diabetes mellitus (NIDDM) patients with secondary failure are controversial. We evaluated the efficacy, side effects, and quality of life of patients receiving insulin either alone or in combination with their previous oral hypoglycemic agents (OHAs).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Fructosamine,
http://linkedlifedata.com/resource/pubmed/chemical/Gliclazide,
http://linkedlifedata.com/resource/pubmed/chemical/Glipizide,
http://linkedlifedata.com/resource/pubmed/chemical/Glyburide,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hexosamines,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Metformin,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
307-14
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7555472-Analysis of Variance,
pubmed-meshheading:7555472-Biological Markers,
pubmed-meshheading:7555472-Blood Glucose,
pubmed-meshheading:7555472-Body Mass Index,
pubmed-meshheading:7555472-C-Peptide,
pubmed-meshheading:7555472-Cholesterol,
pubmed-meshheading:7555472-Cholesterol, HDL,
pubmed-meshheading:7555472-Diabetes Mellitus, Type 2,
pubmed-meshheading:7555472-Drug Therapy, Combination,
pubmed-meshheading:7555472-Female,
pubmed-meshheading:7555472-Fructosamine,
pubmed-meshheading:7555472-Gliclazide,
pubmed-meshheading:7555472-Glipizide,
pubmed-meshheading:7555472-Glyburide,
pubmed-meshheading:7555472-Hemoglobin A, Glycosylated,
pubmed-meshheading:7555472-Hexosamines,
pubmed-meshheading:7555472-Humans,
pubmed-meshheading:7555472-Hypoglycemic Agents,
pubmed-meshheading:7555472-Insulin,
pubmed-meshheading:7555472-Male,
pubmed-meshheading:7555472-Metformin,
pubmed-meshheading:7555472-Middle Aged,
pubmed-meshheading:7555472-Treatment Failure,
pubmed-meshheading:7555472-Triglycerides
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
|
|
pubmed:affiliation |
Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
